Results 21 to 30 of about 591,763 (265)
Regulatory landscape with U.S. patient requirements and Clinical Trial Diversity expectations
The Food and Drug Administration (FDA) has an expectation that products filed for marketing authorization have to include data that are representative of the US patient population.
Elizabeth George +6 more
doaj +1 more source
Reducing injection-site pain (ISP) in patients with chronic conditions such as growth hormone deficiency is a valuable strategy to improve patient compliance and therapeutic efficiency.
Bita Taghizadeh +4 more
doaj +1 more source
RETRACTED: Patient Compliance: Fact or Fiction?
This article has been retracted: please see INNOVATIONS in pharmacy retraction policy (https://pubs.lib.umn.edu/index.php/innovations/policies). This article has been retracted by the Editor and Publisher due to the inappropriate use of previously ...
AK Mohiuddin
doaj +1 more source
Background: Patients’ non-adherence to medication affects both patients themselves and healthcare systems. Consequences include higher mortality, worsening of disease, patient injuries, and increased healthcare costs.
Rønnaug Eline Larsen +8 more
doaj +1 more source
Patient compression compliance: Winning the battle
Not ...
Terri Morrison
doaj +1 more source
Chronic Kidney Patients (CKP) present a negative clinical status, with structural and functional changes in the musculoskeletal system and mental health partly due to a sedentary lifestyle. An effective physical stimulus for CKP is as important as to be
Sergio Calonge Pascual +7 more
doaj +1 more source
The problem of patient compliance with treatment for respiratory infections
Patient compliance describes the degree, to which a patient follows treatment regimen. At present, non-compliance with medical recommendations is one of the key problems for outpatient practice.
A. A. Zaytsev, A. I. Sinopalnikov
doaj +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Adherence to Antiretroviral Therapy and Its Determinants in HIV Patients in Mashhad, IRAN, 2018: a Prospective Study [PDF]
Introduction:Proper adherence to antiretroviral therapy (ART) provides good viral load suppression, while poor adherence can give rise to resistant strains and failure of the treatment.
Amin Bojdy +3 more
doaj +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source

